In the face of the greatest public health crisis in a century, Feinberg’s Institute for Public Health and Medicine (IPHAM) mobilized with leading-edge science, new grant programs for community partners and a series of informational webinars.
A brief course of immunotherapy resulted in complete and near complete remission in nearly two-thirds of previously untreated patients with classical Hodgkin lymphoma, according to a Northwestern Medicine trial.
Measuring acid reflux with a wireless electrode can help clinicians determine if patients can stop taking proton pump inhibitors, a medication commonly prescribed for gastroesophageal reflux disease.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety and health of every patient, physician and staff member.
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
Lifestyle advice has been only somewhat effective in controlling or slowing the progression of nonalcoholic fatty liver disease in children, according to a recent study published in Gastroenterology.
A novel deep brain stimulation device significantly improved quality of life for patients with advanced Parkinson’s disease while also reducing common physical side effects from medication, according to findings published in The Lancet Neurology.
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.